Whitingham, VT, United States of America

Bryan Krastins

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: B.r.a.h.m.s Gmbh. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bryan Krastins: Innovator in Biomarker Detection

Introduction

Bryan Krastins is a notable inventor based in Whitingham, Vermont. He has made significant contributions to the field of biomarker detection, particularly through his innovative patent related to free histone proteins.

Latest Patents

Bryan Krastins holds a patent for "Free histone proteins as biomarkers." This invention relates to a method for detecting free histone proteins in biological samples. The patent outlines the use of immunoassays or mass spectrometric assays for detection. It also describes methods for diagnosing, prognosing, assessing risk, stratifying risk, and controlling therapy for various diseases or medical conditions. The presence of free histone proteins or their peptide fragments in a biological sample is indicative of specific diseases or medical conditions.

Career Highlights

Bryan is associated with B.R.A.H.M.S GmbH, where he applies his expertise in biomarker research. His work focuses on advancing diagnostic methods that can significantly impact patient care and treatment outcomes.

Collaborations

Throughout his career, Bryan has collaborated with esteemed colleagues, including Maryann Stephanie Vogelsang and Anne Incamps. These collaborations have further enriched his research and innovation in the field.

Conclusion

Bryan Krastins is a pioneering inventor whose work in biomarker detection has the potential to transform medical diagnostics. His contributions are vital in understanding and managing various diseases effectively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…